Es gab 50 kürzliche Insider-Transaktionen für Ra Medical Systems, Inc. (RMED), darunter 31 Käufe und 16 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $165.08K und die gesamten Insider-Verkäufe auf $42.25K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Jenkins David A, Colombatto Martin J, Caruso James Joseph. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — RMED
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-01-19 |
Jenkins David A |
Executive Chairman and CEO |
Informierter Kauf |
8,470 |
$0.42 |
$3.59K |
310,800 |
| 2024-01-18 |
Jenkins David A |
Executive Chairman and CEO |
Informierter Kauf |
8,470 |
$0.41 |
$3.49K |
302,330 |
| 2024-01-16 |
Jenkins David A |
Executive Chairman and CEO |
Informierter Kauf |
7,793 |
$0.39 |
$3.01K |
285,390 |
| 2024-01-08 |
Colombatto Martin J |
Director |
RSU-Zuteilung |
25,000 |
$0.40 |
$10K |
25,000 |
| 2024-01-08 |
Caruso James Joseph |
Director |
RSU-Zuteilung |
25,000 |
$0.40 |
$10K |
25,000 |
| 2024-01-08 |
Francis, John P. |
Director |
RSU-Zuteilung |
25,000 |
$0.40 |
$10K |
25,000 |
| 2024-01-08 |
Thomassen Margrit |
Interim CFO and Secretary |
RSU-Zuteilung |
25,000 |
$0.40 |
$10K |
25,000 |
| 2024-01-02 |
Francis, John P. |
Director |
Veräußerung |
11,481 |
- |
- |
- |
| 2023-04-01 |
Passey Steven K |
Chief Financial Officer |
Veräußerung |
- |
- |
- |
- |
| 2023-03-23 |
Jenkins David A |
Ex. Chairman of the Board |
Umwandlung (Verkauf) |
2 |
- |
- |
19 |
| 2023-03-23 |
Caruso James Joseph |
Director |
Umwandlung (Verkauf) |
2 |
- |
- |
8 |
| 2023-03-23 |
Meline Susanne |
Director |
Umwandlung (Verkauf) |
3 |
- |
- |
11 |
| 2023-01-09 |
Thomassen Margrit |
Interim CFO and Secretary |
Veräußerung |
16,764 |
$0.59 |
$9.89K |
- |
| 2023-01-09 |
Jenkins David A |
Executive Chairman of Board |
Unbekannt |
- |
- |
- |
- |
| 2023-01-09 |
Jenkins David A |
Executive Chairman of Board |
RSU-Zuteilung |
21 |
- |
- |
21 |
| 2023-01-09 |
Caruso James Joseph |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-01-09 |
Caruso James Joseph |
Director |
RSU-Zuteilung |
10 |
- |
- |
10 |
| 2023-01-09 |
Meline Susanne |
Director |
RSU-Zuteilung |
14 |
- |
- |
14 |
| 2022-11-20 |
Mcguire Jonathan Will |
CEO & Secretary |
RSU-Steuereinbehalt |
84 |
$2.67 |
$224.28 |
1,083 |
| 2022-07-14 |
Conn Brian |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-05-20 |
Mcguire Jonathan Will |
Chief Executive Officer |
RSU-Steuereinbehalt |
4,241 |
$0.30 |
$1.28K |
62,480 |
| 2022-05-20 |
Jackson Andrew C. |
CFO |
RSU-Steuereinbehalt |
1,361 |
$0.30 |
$410.07 |
21,680 |
| 2021-11-22 |
Mcguire Jonathan Will |
Chief Executive Officer |
Informierter Verkauf |
8,149 |
$2.62 |
$21.35K |
66,721 |
| 2021-11-22 |
Jackson Andrew C. |
CFO |
Informierter Verkauf |
2,684 |
$2.62 |
$7.03K |
23,041 |
| 2021-11-20 |
Mcguire Jonathan Will |
Chief Executive Officer |
Aktienrückgabe |
34,752 |
- |
- |
74,870 |
| 2021-11-20 |
Jackson Andrew C. |
CFO |
Aktienrückgabe |
11,759 |
- |
- |
25,725 |
| 2021-06-04 |
Colombatto Martin J |
Director |
RSU-Zuteilung |
4,000 |
- |
- |
29,439 |
| 2021-06-04 |
Mejia Richard Jr |
Director |
RSU-Zuteilung |
4,000 |
- |
- |
21,946 |
| 2021-06-04 |
Stafslien Joan |
Director |
RSU-Zuteilung |
4,000 |
- |
- |
8,410 |
| 2021-06-04 |
Enquist William R |
Director |
RSU-Zuteilung |
4,000 |
- |
- |
18,766 |
| 2021-06-04 |
Meline Susanne |
Director |
RSU-Zuteilung |
4,000 |
- |
- |
9,808 |
| 2021-05-20 |
Mcguire Jonathan Will |
Chief Executive Officer |
RSU-Steuereinbehalt |
216 |
$3.15 |
$680.40 |
109,622 |
| 2021-02-03 |
Meline Susanne |
Director |
RSU-Zuteilung |
4,000 |
- |
- |
5,808 |
| 2021-01-31 |
Meline Susanne |
Director |
Veräußerung |
- |
- |
- |
1,808 |
| 2021-01-05 |
Colombatto Martin J |
Director |
RSU-Zuteilung |
10,000 |
- |
- |
25,439 |
| 2021-01-05 |
Saad Mark E |
Director |
RSU-Zuteilung |
8,227 |
- |
- |
13,750 |
| 2021-01-05 |
Mejia Richard Jr |
Director |
RSU-Zuteilung |
9,423 |
- |
- |
17,946 |
| 2021-01-05 |
Enquist William R |
Director |
RSU-Zuteilung |
7,243 |
- |
- |
14,766 |
| 2020-11-20 |
Mcguire Jonathan Will |
Chief Executive Officer |
RSU-Steuereinbehalt |
216 |
$6.39 |
$1.38K |
109,838 |
| 2020-11-20 |
Kraws Jeffrey J |
Co-president |
RSU-Zuteilung |
200 |
$5.43 |
$1.09K |
5,533 |
| 2020-11-20 |
Jackson Andrew C. |
CFO |
RSU-Zuteilung |
200 |
$5.43 |
$1.09K |
37,484 |
| 2020-11-20 |
Horwood Daniel |
General Counsel |
RSU-Zuteilung |
200 |
$5.43 |
$1.09K |
21,896 |
| 2020-11-19 |
Colombatto Martin J |
Director |
Informierter Kauf |
8,700 |
$5.78 |
$50.28K |
15,439 |
| 2020-11-19 |
Stafslien Joan |
Director |
Informierter Kauf |
4,410 |
$5.67 |
$25K |
4,410 |
| 2020-11-19 |
Mejia Richard Jr |
Director |
Informierter Kauf |
1,000 |
$5.82 |
$5.82K |
8,523 |
| 2020-11-19 |
Enquist William R |
Director |
Informierter Kauf |
5,263 |
$5.82 |
$30.62K |
5,263 |
| 2020-11-17 |
Mcguire Jonathan Will |
Chief Executive Officer |
RSU-Zuteilung |
104,254 |
- |
- |
110,054 |
| 2020-11-17 |
Jackson Andrew C. |
CFO |
RSU-Zuteilung |
35,276 |
- |
- |
37,284 |
| 2020-11-17 |
Horwood Daniel |
General Counsel |
RSU-Zuteilung |
19,591 |
- |
- |
21,696 |
| 2020-10-12 |
Colombatto Martin J |
Director |
RSU-Zuteilung |
100,000 |
- |
- |
168,475 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall